Follow-up of four HIV-infected individuals after administration of hepatitis C virus and GBV-C hepatitis G virus contaminated intravenous immunoglobulin: Evidence for HCV but not for GBV-C/HGV transmission

被引:0
作者
Berger, A
Doerr, HW
Scharrer, I
Weber, B
机构
[1] UNIV FRANKFURT KLINIKUM,ZENTRUM INNEREN MED,ABT ANGIOL,D-60596 FRANKFURT,GERMANY
[2] LABS REUNIS KUTTER LIENERS HASTERT,LUXEMBOURG,GERMANY
关键词
acute HCV infection; GBV-C/HGV; HIV; PCR; anti-E2; antibody; intravenous immunoglobulin;
D O I
10.1002/(SICI)1096-9071(199709)53:1<25::AID-JMV5>3.0.CO;2-S
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
In 1994, hepatitis C virus (HCV) infection was transmitted to four HIV seropositive patients attending the Department of Angiology, University Clinics, Frankfurt am Main, by the administration of Gammagard(R). The patients were suffering from thrombocytopenia and received betweeen 20 and 30 g of the contaminated lot 93F21AB11. GBV-C/HGV RNA could be amplified from the Gammagard(R) lot 93F21AB11 using 5'NCR and NS5 primer pairs. All the four patients were negative in the GBV-C/HGV RT-PCR prior to therapy and until the end of the followup period. GBV-C/HGV IgG antibodies to the putative envelope (E2) were detected using the E2 HGV-env kit (Boehringer-Mannheim, Germany) in Gammagard(R) lot 93F21AB11 and in one patient before donation of immunoglobulin. Anti-E2 seroconversion was observed in one recipient, the other two patients remained anti-E2 seronegative until the end of the observation period. It is concluded that there is no direct evidence for transmission of GBV-C/HGV by contaminated intravenous immunoglobulin since GBV-C/HGV RNA was not detected in the recipients up to 1 year after administration. (C) 1997 Wiley-Liss, Inc.
引用
收藏
页码:25 / 30
页数:6
相关论文
共 13 条
[1]   Lack of correlation between different hepatitis C virus screening and confirmatory assays [J].
Berger, A ;
Doerr, HW ;
Preiser, W ;
Weber, B .
JOURNAL OF VIROLOGICAL METHODS, 1996, 59 (1-2) :141-146
[2]   HEPATITIS-C VIRUS VIREMIA FOLLOWING CLINICAL RESOLUTION OF ACUTE HEPATITIS-C [J].
GIUBERTI, T ;
MARIN, MG ;
FERRARI, C ;
MARCHELLI, S ;
SCHIANCHI, C ;
ANTONI, AMD ;
PIZZOCOLO, G ;
FIACCADORI, F .
JOURNAL OF HEPATOLOGY, 1994, 20 (05) :666-671
[3]   Infection with hepatitis G virus among recipients of plasma products [J].
Jarvis, LM ;
Davidson, F ;
Hanley, JP ;
Yap, PL ;
Ludlam, CA ;
Simmonds, P .
LANCET, 1996, 348 (9038) :1352-1355
[4]  
KUROSAKI M, 1993, HEPATOLOGY, V18, P1293, DOI 10.1002/hep.1840180602
[5]   Molecular cloning and disease association of hepatitis G virus: A transfusion-transmissible agent [J].
Linnen, J ;
Wages, J ;
ZhangKeck, ZY ;
Fry, KE ;
Krawczynski, KZ ;
Alter, H ;
Koonin, E ;
Gallagher, M ;
Alter, M ;
Hadziyannis, S ;
Karayiannis, P ;
Fung, K ;
Nakatsuji, Y ;
Shih, JWK ;
Young, L ;
Piatak, M ;
Hoover, C ;
Fernandez, J ;
Chen, S ;
Zou, JC ;
Morris, T ;
Hyams, KC ;
Ismay, S ;
Lifson, JD ;
Hess, G ;
Foung, SKH ;
Thomas, H ;
Bradley, D ;
Margolis, H ;
Kim, JP .
SCIENCE, 1996, 271 (5248) :505-508
[6]   SERIAL QUANTITATIVE-ANALYSIS OF SERUM HEPATITIS-C VIRUS-RNA LEVEL IN PATIENTS WITH ACUTE AND CHRONIC HEPATITIS-C [J].
NAITO, M ;
HAYASHI, N ;
HAGIWARA, H ;
KATAYAMA, K ;
KASAHARA, A ;
FUSAMOTO, H ;
KATO, M ;
MASUZAWA, M ;
KAMADA, T .
JOURNAL OF HEPATOLOGY, 1994, 20 (06) :755-759
[7]  
NUBLING CM, 1995, LANCET, V345, P1174
[8]  
RABENAU H, 1995, LAB MED, V19, P523
[9]   ISOLATION OF NOVEL VIRUS-LIKE SEQUENCES ASSOCIATED WITH HUMAN HEPATITIS [J].
SIMONS, JN ;
LEARY, TP ;
DAWSON, GJ ;
PILOTMATIAS, TJ ;
MUERHOFF, AS ;
SCHLAUDER, GG ;
DESAI, SM ;
MUSHAHWAR, IK .
NATURE MEDICINE, 1995, 1 (06) :564-569
[10]   Detection of antibodies to a putative hepatitis G virus envelope protein [J].
Tacke, M ;
Kiyosawa, K ;
Stark, K ;
Schlueter, V ;
OfenlochHaehnle, B ;
Hess, G ;
Engel, AM .
LANCET, 1997, 349 (9048) :318-320